Four Pharmacists Found Guilty In Remdesivir Scam

Kanpur : Four pharmacists have been found guilty in the Remdesivir scam at Lala Lajpat Rai (LLR) hospital, where injections were allegedly issued in the name of dead Covid-19 patients.

The committee headed by the chief development officer (CDO) has submitted the report to district magistrate (DM) Alok Tiwari. “The probe report has been received and four pharmacists have been found guilty. Action will be taken against them soon,” said the DM.

The doctors, meanwhile, have been given a clean chit in this case. Other employees have also been acquitted. These injections were issued from the store in the name of the two patients who had already died due to coronavirus.

During the second wave of Covid-19 pandemic, there was a crisis of Remdesivir injections in the market. People were ready to spend Rs 50,000 to Rs 55,000 for procuring the injection.

Taking advantage of this, black-marketeers started selling injections at premium rates.

Police had then arrested four persons including two nursing staff of LLR hospital for selling injections.

A few days later, it came to light that Remdesivir injections were issued against the names of the two Covid -19 patients admitted to the hospital, and who had already died. “Those injections were also shown to be administered to patients,” sources at LLR said.

The matter was brought to the knowledge of then principal of GSVM Medical college Prof. RB Kamal under whose jurisdiction the hospital comes.

On the basis of the report of the inquiry committee, he suspended the sister in-charge and pharmacist of the neuroscience centre of Covid-19 in the hospital and issued show-cause notices to eight nursing staff.

At the same time, the DM also ordered an inquiry. A three-member investigation team was formed under the supervision of CDO Mahendra Kumar, in which ADM (City) Atul Kumar and CMO were also included.

The committee has recommended action in the report considering four pharmacists guilty.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states